US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Direxion Daily S&P Biotech Bull 3x Shares

249.65

-16.1400-6.07%

Post-market: 251.501.85+0.74%19:39 EDT

Volume:444.58K

Turnover:115.12M

Market Cap:567.83M

PE:- -

High:271.79

Open:261.76

Low:248.93

Close:265.79

52wk High:341.93

52wk Low:93.20

Shares:2.27M

Float Shares:2.27M

Volume Ratio:1.37

T/O Rate:19.55%

Dividend:0.90

Dividend Rate:0.36%

ROE:--

ROA:--

PB:--

PE(LYR):- -

Loading ...

Overview Company News Filings

Sunway Healthcare Extends Heads of Agreement for Hospital Project with Putrajaya Holdings

MT Newswires Live

Optiscan Imaging Lodges Submission Seeking US FDA Approval for Digital Pathology Device; Shares Rise 4%

MT Newswires Live

Optiscan Files FDA 510(k) for InForm Digital Pathology Device

Stemcyte Submits Regenerative Medical Drug Application to Taiwan FDA; Shares Up 10%

MT Newswires Live

Stemcyte Submits Regenerative Medical Drug Application to Taiwan FDA

MT Newswires Live

Promisia completes Chatswood Retirement Village deal with share and note issue

HealthCo Healthcare & Wellness REIT (HCW) Gets a Buy from Macquarie

Austco Healthcare Issues New Unquoted Performance Rights Under Incentive Scheme

LTR Pharma completes FDA pharmacokinetic dataset as SPONTAN shows rapid absorption and strong safety

Grindr to Acquire PurposeMed, Expanding LGBTQ+ Healthcare

Trump Sending $500 Checks with Letter Touting Healthcare Record

MoonLake files FDA application for sonelokimab therapy

Health Care Roundup: Market Talk

Healthcare Stocks Fall Amid Above-Target Inflation

NewGenIvf Group Closes $1.25 Million Public Offering to Fund Tech and Healthcare Expansion

Bristol-Myers Squibb's Camzyos to Treat Heart Condition Receives FDA Approval for Pediatric Patients

MT Newswires Live

Ceribell Earns Buy Rating as New FDA-Cleared Clarity Software Strengthens ICU Adoption and Long-Term Growth Outlook

FDA approves Bristol Myers’ Camzyos capsules for children with oHCM

Healthcare Triangle signs MOU for AI-enabled humanoid nursing robots

Analysts Are Bullish on Top Healthcare Stocks: Jade Biosciences (JBIO), Liquidia Technologies (LQDA)

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://hk.tigershowtime.com/stock/LABU/news?page=2"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"LABU","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"LABU\",,,,,undefined,":{"symbol":"LABU","market":"US","secType":"STK","nameCN":"Direxion Daily S&P Biotech Bull 3x Shares","latestPrice":249.65,"timestamp":1790884800000,"preClose":265.79,"halted":0,"volume":444576,"hourTrading":{"tag":"盘后","latestPrice":251.5,"preClose":249.65,"latestTime":"19:39 EDT","volume":3519,"amount":886075.47288,"timestamp":1790897987407,"change":1.85,"changeRate":0.00741,"amplitude":0.011496},"delay":0,"changeRate":-0.060724632228451085,"floatShares":2274486,"shares":2274486,"eps":0,"marketStatus":"Post-Mkt","change":-16.14,"latestTime":"10-01 19:52:21 EDT","open":261.76,"high":271.79,"low":248.93,"amount":115118767.29408,"amplitude":0.086008,"askPrice":253.46,"askSize":9,"bidPrice":251.5,"bidSize":2,"shortable":3,"etf":3,"ttmEps":0,"tradingStatus":3,"nextMarketStatus":{"tag":"Closed","tradingStatus":0,"beginTime":1790899200000},"marketStatusCode":4,"adr":0,"adrRate":0,"exchange":"ARCA","adjPreClose":265.79,"sharesOutstanding":3074486,"nav":260.661,"aum":592869955.42,"dividendRate":0.00362,"bidAskSpread":0.003436,"preHourTrading":{"tag":"盘前","latestPrice":261.6,"preClose":265.79,"latestTime":"09:29 EDT","volume":2318,"amount":612617.1732800001,"timestamp":1790861345993,"change":-4.19,"changeRate":-0.015764,"amplitude":0.02976},"postHourTrading":{"tag":"盘后","latestPrice":251.5,"preClose":249.65,"latestTime":"19:39 EDT","volume":3519,"amount":886075.47288,"timestamp":1790897987407,"change":1.85,"changeRate":0.00741,"amplitude":0.011496},"volumeRatio":1.368468,"impliedVol":0.9424,"impliedVolPercentile":0.6056},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"LABU\",,,,,undefined,":{"symbol":"LABU","floatShares":2274486,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":1.368468,"shares":2274486,"dividePrice":0.9037,"high":271.79,"amplitude":0.086008,"preClose":265.79,"low":248.93,"week52Low":93.2,"pbRate":"--","week52High":341.93,"institutionHeld":0,"latestPrice":249.65,"committee":-0.636364,"eps":0,"divideRate":0.00362,"volume":444576,"delay":0,"ttmEps":0,"open":261.76,"prevYearClose":159.39,"prevWeekClose":252.47,"prevMonthClose":265.79,"prevQuarterClose":265.79,"fiveDayClose":257.32,"twentyDayClose":311.81,"sixtyDayClose":317.19},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/LABU\",params:#limit:5,,,undefined,":[{"date":"2025-09-23","symbol":"LABU","amount":0.10273,"announcedDate":"2025-09-22","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-09-23","defaultRemindTime":1758634200000,"name":"三倍做多标普生物-Direxion","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-09-30","payableDate":"2025-09-23","currency":"USD","dateTimestamp":1758600000000,"payDate":"2025-09-30"},{"date":"2025-06-24","symbol":"LABU","amount":0.21897,"announcedDate":"2025-06-23","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-06-24","defaultRemindTime":1750771800000,"name":"三倍做多标普生物-Direxion","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-07-01","payableDate":"2025-06-24","currency":"USD","dateTimestamp":1750737600000,"payDate":"2025-07-01"},{"date":"2025-03-25","symbol":"LABU","amount":0.10714,"announcedDate":"2025-03-24","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-03-25","defaultRemindTime":1742909400000,"name":"三倍做多标普生物-Direxion","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-04-01","payableDate":"2025-03-25","currency":"USD","dateTimestamp":1742875200000,"payDate":"2025-04-01"},{"date":"2024-06-25","symbol":"LABU","amount":0.15021,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2024-06-25","defaultRemindTime":1719322200000,"name":"三倍做多标普生物-Direxion","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2024-07-02","payableDate":"2024-06-25","currency":"USD","dateTimestamp":1719288000000,"payDate":"2024-07-02"},{"date":"2024-03-19","symbol":"LABU","amount":0.16064,"announcedDate":"2024-03-18","type":"dividend","market":"US","newRecordDate":"2024-03-20","defaultRemindTime":1710855000000,"name":"三倍做多标普生物-Direxion","recordDate":"2024-03-26","payableDate":"2024-03-20","currency":"USD","dateTimestamp":1710820800000,"payDate":"2024-03-26"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"LABU\",market:\"US\",,,undefined,":[{"executeDate":"2018-06-19","recordDate":"2018-06-20","paymentDate":"2018-06-26","value":0.01932,"currency":"USD"},{"executeDate":"2018-09-25","recordDate":"2018-09-26","paymentDate":"2018-10-02","value":0.0954,"currency":"USD"},{"executeDate":"2018-12-27","recordDate":"2018-12-28","paymentDate":"2019-01-04","value":0.09621,"currency":"USD"},{"executeDate":"2019-03-19","recordDate":"2019-03-20","paymentDate":"2019-03-26","value":0.10973,"currency":"USD"},{"executeDate":"2019-06-25","recordDate":"2019-06-26","paymentDate":"2019-07-02","value":0.03745,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"LABU\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"LABU\",pageSize:20,pageCount:2,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2672573233","title":"Sunway Healthcare Extends Heads of Agreement for Hospital Project with Putrajaya Holdings","url":"https://stock-news.laohu8.com/highlight/detail?id=2672573233","media":"MT Newswires Live","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672573233?lang=en_us&edition=fundamental","pubTime":"2026-10-01 13:49","pubTimestamp":1790833797,"startTime":"0","endTime":"0","summary":"Sunway Healthcare  has signed a supplemental deal with Putrajaya Holdings to further extend the term of their heads of agreement to Oct. 31, according to a Wednesday Bursa Malaysia filing.The extension is linked to a proposed joint venture for the construction and lease of a multi-specialty tertiary private hospital, Sunway Medical Center.The companies have made substantial progress toward concluding the agreements, with the extension providing both parties with sufficient time to finalize documentation.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["HCSG","LABU","XBI","XLV","LU0029874061.USD","BK4588","LU0128526141.USD","BK4581","BK4137","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672732334","title":"Optiscan Imaging Lodges Submission Seeking US FDA Approval for Digital Pathology Device; Shares Rise 4%","url":"https://stock-news.laohu8.com/highlight/detail?id=2672732334","media":"MT Newswires Live","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672732334?lang=en_us&edition=fundamental","pubTime":"2026-10-01 13:48","pubTimestamp":1790833700,"startTime":"0","endTime":"0","summary":"Optiscan Imaging  lodged a 510 submission with the US Food and Drug Administration  for its InForm medical imaging device designed for pathology workflows, according to a Thursday filing with the Australian bourse.The submission moves the device beyond its internal development, testing, and validation phase into a formal regulatory assessment process, with clearance being a precursor to its commercial marketing within the US.The company said the US represents a \"substantial commercial opportunity\" for InForm given that its pathology market is still largely analogue and is only now starting to shift toward digital workflows.Optiscan Imaging shares rose 4% in recent Thursday trade.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK7007","LABU","BK4585","OIL.AU","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672343437","title":"Optiscan Files FDA 510(k) for InForm Digital Pathology Device","url":"https://stock-news.laohu8.com/highlight/detail?id=2672343437","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672343437?lang=en_us&edition=fundamental","pubTime":"2026-10-01 12:57","pubTimestamp":1790830655,"startTime":"0","endTime":"0","summary":"Optiscan Imaging Limited ( ($AU:OIL) ) has provided an announcement. Optiscan Imaging has lodged a 510(k) submission with the U.S. Food and Drug Ad...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/optiscan-files-fda-510k-for-inform-digital-pathology-device?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/optiscan-files-fda-510k-for-inform-digital-pathology-device?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LABU","OIL","BK4585","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672731739","title":"Stemcyte Submits Regenerative Medical Drug Application to Taiwan FDA; Shares Up 10%","url":"https://stock-news.laohu8.com/highlight/detail?id=2672731739","media":"MT Newswires Live","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672731739?lang=en_us&edition=fundamental","pubTime":"2026-10-01 12:38","pubTimestamp":1790829533,"startTime":"0","endTime":"0","summary":"Stemcyte International's (TPE:4178) major unit, StemCyte, submitted a new drug application to the Taiwan Food and Drug Administration (TFDA) for REGENECYTE, a regenerative medicinal product used in un","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4588","BK4585","LABU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672731402","title":"Stemcyte Submits Regenerative Medical Drug Application to Taiwan FDA","url":"https://stock-news.laohu8.com/highlight/detail?id=2672731402","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672731402?lang=en_us&edition=fundamental","pubTime":"2026-10-01 12:33","pubTimestamp":1790829187,"startTime":"0","endTime":"0","summary":"Stemcyte International's (TPE:4178) major unit, StemCyte, submitted a new drug application to the Taiwan Food and Drug Administration (TFDA) for REGENECYTE, a regenerative medicinal product used in un","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4585","LABU","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672731986","title":"Promisia completes Chatswood Retirement Village deal with share and note issue","url":"https://stock-news.laohu8.com/highlight/detail?id=2672731986","media":"TIPRANKS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672731986?lang=en_us&edition=fundamental","pubTime":"2026-10-01 12:18","pubTimestamp":1790828311,"startTime":"0","endTime":"0","summary":"An announcement from Promisia Healthcare Limited ( ($NZ:PHL) ) is now available. Promisia Healthcare has completed the acquisition of Chatswood Ret...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/promisia-completes-chatswood-retirement-village-deal-with-share-and-note-issue?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/promisia-completes-chatswood-retirement-village-deal-with-share-and-note-issue?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4588","BK4585","XLV","BK4581","XBI","LABU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672358733","title":"HealthCo Healthcare & Wellness REIT (HCW) Gets a Buy from Macquarie","url":"https://stock-news.laohu8.com/highlight/detail?id=2672358733","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672358733?lang=en_us&edition=fundamental","pubTime":"2026-10-01 07:35","pubTimestamp":1790811334,"startTime":"0","endTime":"0","summary":"In a report released today, from Macquarie maintained a Buy rating on HealthCo Healthcare & Wellness REIT, with a price target of A$0.83. Currently...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/healthco-healthcare-wellness-reit-hcw-gets-a-buy-from-macquarie-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/healthco-healthcare-wellness-reit-hcw-gets-a-buy-from-macquarie-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["RJMG","XLV","BPRE","BK4585","BK4588","XBI","IQRA","PSCF","REIT","YLDW","LABU","IVRA","MDIV","BK4581","RNTY","DFRA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672273820","title":"Austco Healthcare Issues New Unquoted Performance Rights Under Incentive Scheme","url":"https://stock-news.laohu8.com/highlight/detail?id=2672273820","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672273820?lang=en_us&edition=fundamental","pubTime":"2026-10-01 07:15","pubTimestamp":1790810128,"startTime":"0","endTime":"0","summary":"Austco Healthcare Limited ( ($AU:AHC) ) just unveiled an update. Austco Healthcare Limited has notified the market of the issue of 2,548,312 unquot...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/austco-healthcare-issues-new-unquoted-performance-rights-under-incentive-scheme?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/austco-healthcare-issues-new-unquoted-performance-rights-under-incentive-scheme?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LABU","BK4137","LU0128526141.USD","BK4585","XBI","BK4581","XLV","LU0029874061.USD","HCSG","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672738248","title":"LTR Pharma completes FDA pharmacokinetic dataset as SPONTAN shows rapid absorption and strong safety","url":"https://stock-news.laohu8.com/highlight/detail?id=2672738248","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672738248?lang=en_us&edition=fundamental","pubTime":"2026-10-01 07:14","pubTimestamp":1790810053,"startTime":"0","endTime":"0","summary":"The latest announcement is out from LTR Pharma Limited ( ($AU:LTP) ). LTR Pharma has released the final Phase II clinical study report for its intr...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/ltr-pharma-completes-fda-pharmacokinetic-dataset-as-spontan-shows-rapid-absorption-and-strong-safety?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/ltr-pharma-completes-fda-pharmacokinetic-dataset-as-spontan-shows-rapid-absorption-and-strong-safety?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4585","BK4588","LABU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672544780","title":"Grindr to Acquire PurposeMed, Expanding LGBTQ+ Healthcare","url":"https://stock-news.laohu8.com/highlight/detail?id=2672544780","media":"TIPRANKS","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672544780?lang=en_us&edition=fundamental","pubTime":"2026-10-01 05:31","pubTimestamp":1790803912,"startTime":"0","endTime":"0","summary":"Grindr ( ($GRND) ) just unveiled an announcement. On September 30, 2026, Grindr Inc. announced its first major acquisition, agreeing to buy Purpose...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/grindr-to-acquire-purposemed-expanding-lgbtq-healthcare?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/grindr-to-acquire-purposemed-expanding-lgbtq-healthcare?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LABU","LU0029874061.USD","XLV","BK4585","XBI","BK4588","LU0128526141.USD","HCSG","BK4137","BK4581","SOCL"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672787242","title":"Trump Sending $500 Checks with Letter Touting Healthcare Record","url":"https://stock-news.laohu8.com/highlight/detail?id=2672787242","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672787242?lang=en_us&edition=fundamental","pubTime":"2026-10-01 05:12","pubTimestamp":1790802720,"startTime":"0","endTime":"0","summary":"WASHINGTON-President Trump began sending $500 checks to nearly one million people and enclosed a letter touting his record on cutting healthcare costs, just a month before voters go to the polls for t","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LABU","BK4588","XLV","BK4585","LU0128526141.USD","BK4137","LU0029874061.USD","BK4581","XBI","HCSG"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672787143","title":"MoonLake files FDA application for sonelokimab therapy","url":"https://stock-news.laohu8.com/highlight/detail?id=2672787143","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672787143?lang=en_us&edition=fundamental","pubTime":"2026-10-01 04:53","pubTimestamp":1790801622,"startTime":"0","endTime":"0","summary":"MoonLake Immunotherapeutics ( ($MLTX) ) has issued an update. On September 30, 2026, MoonLake Immunotherapeutics submitted a Biologics License Appl...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/moonlake-files-fda-application-for-sonelokimab-therapy?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/moonlake-files-fda-application-for-sonelokimab-therapy?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4585","BK4588","LABU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672876367","title":"Health Care Roundup: Market Talk","url":"https://stock-news.laohu8.com/highlight/detail?id=2672876367","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672876367?lang=en_us&edition=fundamental","pubTime":"2026-10-01 04:50","pubTimestamp":1790801400,"startTime":"0","endTime":"0","summary":"The latest Market Talks covering the Health Care sector. Published exclusively on Dow Jones Newswires at 4:20 ET, 12:20 ET and 16:50 ET.0508 ET - Investors are dialing up their bets on the life-scienc","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","XBI","BK4581","XLV","BK4585","LABU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672538787","title":"Healthcare Stocks Fall Amid Above-Target Inflation","url":"https://stock-news.laohu8.com/highlight/detail?id=2672538787","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672538787?lang=en_us&edition=fundamental","pubTime":"2026-10-01 04:44","pubTimestamp":1790801040,"startTime":"0","endTime":"0","summary":"The healthcare sector slipped in a mixed day for the broader market, as PCE data kept inflation worries alive with readings well above the Fed's 2% target.A next-generation weight-loss drug from Eli Lilly when combined with Zepbound, helped people lose substantially more weight than Zepbound alone, according to a new study. The experimental injection, eloralintide, which mimics a hormone called amylin that helps signal fullness after eating, was studied in combination with a Zepbound shot in patients with Type 2 diabetes. Patients on the highest dose of the combination lost an average of 23.3% of their body weight over roughly 11 months while those on Zepbound alone lost an average of 14.8% of their weight.United Therapeutics picked up a win in its patent lawsuit against rival Liquidia when a federal judge ruled that two of United Therapeutics' claims were valid and infringed upon. Shares climbed 14%, its biggest single-day gain in over a year. Liquidia shares, meanwhile, were nearly c","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4581","BK4585","LU0029874061.USD","XLV","XBI","HCSG","BK4137","LABU","LU0128526141.USD","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672878247","title":"NewGenIvf Group Closes $1.25 Million Public Offering to Fund Tech and Healthcare Expansion","url":"https://stock-news.laohu8.com/highlight/detail?id=2672878247","media":"TIPRANKS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672878247?lang=en_us&edition=fundamental","pubTime":"2026-10-01 04:28","pubTimestamp":1790800126,"startTime":"0","endTime":"0","summary":"NewGenIvf Group ( ($NIVF) ) just unveiled an update. On September 30, 2026, NewGenIvf Group closed a $1.25 million public offering of 17,857,143 Cl...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/newgenivf-group-closes-1-25-million-public-offering-to-fund-tech-and-healthcare-expansion?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/newgenivf-group-closes-1-25-million-public-offering-to-fund-tech-and-healthcare-expansion?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["HCSG","NIVF","BK4137","BK4588","BK4585","LABU","LU0029874061.USD","XBI","BK4581","BK4196","XLV","LU0128526141.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672784579","title":"Bristol-Myers Squibb's Camzyos to Treat Heart Condition Receives FDA Approval for Pediatric Patients","url":"https://stock-news.laohu8.com/highlight/detail?id=2672784579","media":"MT Newswires Live","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672784579?lang=en_us&edition=fundamental","pubTime":"2026-10-01 03:22","pubTimestamp":1790796162,"startTime":"0","endTime":"0","summary":"Bristol-Myers Squibb's  Camzyos to treat symptomatic obstructive hypertrophic cardiomyopathy was approved by the US Food and Drug Administration for use in pediatric patients, the agency said in a statement Wednesday.Camzyos, which was first approved for adults in 2022, is now approved for both adults and pediatric patients with weight of at least 30 kg with symptomatic oHCM, a genetically inherited condition that causes thickened heart muscle.The company's phase 3 efficacy data revealed improved left ventricular outflow tract obstruction in participants suffering from the heart condition, according to the statement.Camzyos received orphan drug designation for this indication, according to the agency.Price: 62.85, Change: -0.02, Percent Change: -0.02","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["IE00BJT1NW94.SGD","LU1670711123.USD","LU1430594728.SGD","LU0985481810.HKD","LU0456855351.SGD","LU2242652126.USD","LU1868837300.USD","BK4532","BMY","LU0882574055.USD","LU2125154778.USD","LU1032466523.USD","LU0267386448.USD","LU1093756325.SGD","BK4007","BK4559","LU1571399168.USD","LU1670710661.SGD","LU0306806265.USD","LU0114720955.EUR","LU1670711040.USD","BK4588","IE00B2B36J28.USD","LU2125154935.USD","LABU","LU1883839398.USD","BK4534","IE00BFTCPJ56.SGD","BK4581","IHE","IE0002141913.USD","LU1868837136.USD","FTXH","LU1236620750.USD","LU2242646821.SGD","LU0237698245.USD","LU0225771236.USD","IE00BSNM7G36.USD","IE00BFXG1179.USD","BK4585","LU1868836591.USD","LU1236620834.HKD","LU0061475181.USD","LU1718418525.SGD","LU1983299246.USD","IE00BJJMRZ35.SGD","LU1093756168.USD","LU0306807586.USD","LU0432979614.USD","LU1323610961.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672564784","title":"Ceribell Earns Buy Rating as New FDA-Cleared Clarity Software Strengthens ICU Adoption and Long-Term Growth Outlook","url":"https://stock-news.laohu8.com/highlight/detail?id=2672564784","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672564784?lang=en_us&edition=fundamental","pubTime":"2026-10-01 03:15","pubTimestamp":1790795721,"startTime":"0","endTime":"0","summary":"William Blair analyst Brandon Vazquez has reiterated their bullish stance on CBLL stock, giving a Buy rating on September 21. Brandon Vazquez has g...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/ceribell-earns-buy-rating-as-new-fda-cleared-clarity-software-strengthens-icu-adoption-and-long-term-growth-outlook-ratings-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/ceribell-earns-buy-rating-as-new-fda-cleared-clarity-software-strengthens-icu-adoption-and-long-term-growth-outlook-ratings-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["CBLL","LABU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672781299","title":"FDA approves Bristol Myers’ Camzyos capsules for children with oHCM","url":"https://stock-news.laohu8.com/highlight/detail?id=2672781299","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672781299?lang=en_us&edition=fundamental","pubTime":"2026-10-01 02:35","pubTimestamp":1790793349,"startTime":"0","endTime":"0","summary":"The U.S. Food and Drug Administration approved Bristol Myers (BMY)’ Camzyos capsules as the first treatment for children with symptomatic obstructi...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/fda-approves-bristol-myers-camzyos-capsules-for-children-with-ohcm-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/fda-approves-bristol-myers-camzyos-capsules-for-children-with-ohcm-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4588","LABU","LU1670711040.USD","LU0237698245.USD","LU1093756168.USD","LU1868837300.USD","LU2360032135.SGD","LU1718418525.SGD","BK4126","LU1868837136.USD","IHE","BK4007","MYE","LU2125154778.USD","LU0096364046.USD","BMY","BK4585","LU0225284248.USD","FTXH","BK4559","LU0114720955.EUR","LU0306806265.USD","LU1571399168.USD","LU0432979614.USD","LU2242646821.SGD","LU1323610961.USD","LU1868836914.USD","IE00BJT1NW94.SGD","LU0306807586.USD","LU2242652126.USD","LU1430594728.SGD","LU0225771236.USD","BK4534","LU1291159041.SGD","IE00B2B36J28.USD","LU0868494617.USD","LU1074936037.SGD","IE00BFXG1179.USD","LU1989771016.USD","IE00BSNM7G36.USD","LU1883839398.USD","LU2596442595.SGD","IE00BFTCPJ56.SGD","LU1868836757.USD","BK4581","LU0061475181.USD","LU1236620750.USD","LU1585245621.USD","IE0002141913.USD","IE0009355771.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672781296","title":"Healthcare Triangle signs MOU for AI-enabled humanoid nursing robots","url":"https://stock-news.laohu8.com/highlight/detail?id=2672781296","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672781296?lang=en_us&edition=fundamental","pubTime":"2026-10-01 02:25","pubTimestamp":1790792716,"startTime":"0","endTime":"0","summary":"Healthcare Triangle (HCTI) announced that it has entered into a Memorandum of Understanding with AI World Sdn. Bhd., a Malaysian company specializi...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/healthcare-triangle-signs-mou-for-ai-enabled-humanoid-nursing-robots-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/healthcare-triangle-signs-mou-for-ai-enabled-humanoid-nursing-robots-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4588","VTHR","LABU","BK4581","HCTI","XLV","XBI","AGIX","BK4585","CHAT","QTOC","BK4167","AIPO","ARTY"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672781220","title":"Analysts Are Bullish on Top Healthcare Stocks: Jade Biosciences (JBIO), Liquidia Technologies (LQDA)","url":"https://stock-news.laohu8.com/highlight/detail?id=2672781220","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672781220?lang=en_us&edition=fundamental","pubTime":"2026-10-01 02:20","pubTimestamp":1790792406,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Jade Biosciences (JBIO) and Liquidia Technologies (L...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-are-bullish-on-top-healthcare-stocks-jade-biosciences-jbio-liquidia-technologies-lqda-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-are-bullish-on-top-healthcare-stocks-jade-biosciences-jbio-liquidia-technologies-lqda-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["JBIO","LABU","LU0029874061.USD","XLV","LQDA","BK4585","XBI","BK4588","LU0128526141.USD","BK4007","BK4137","BK4539","HCSG","BK4139","BK4581"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":20,"pageCount":2,"totalSize":388,"code":"91000000","status":"200"}]}}